... Prostatic adenocarcinoma Prostatic carcinoma Radical prostatectomy Robotic prostatectomy Robot assisted radical prostatectomy After skin malignancies, genitourinary cancers are the most frequent cancers in kidney transplant recipients. Prostate cancer (PCa) seems to be in the first position...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic carcinoma Prostatectomy Complications, prostatectomy Urologia Intemationalis Original Paper U rollnt 1997;59:30-33 Received: February...

... during surgery or removal of organs for transplantation. The cases analyzed represent normal prostates (n = 4); benign prostatic hyperplasias (n = 10; prostatic carcinomas with Gleason scores of 2-4 (n = 5), 5–7 (n = 10), and 8–10 (n = 3), and prostatic carcinomas treated with hormonal therapy (n = 15...

...Kenjiro Kohri; Takanori Yamate; Hirononi Tsujihashi; Yuzo Nakao; Yoshikazu Katayama; Yasushi Hara; Yasuyuki Morikawa; Takashi Kurita We describe a 62-year-old male with brain metastasis from prostatic carcinoma, which regressed with medical and surgical endocrine therapies. The patient’s presenting...

... months later, cystoscopy showed papillary metastases of the prostatic carcinoma in the bladder. Immunohistochemistry and flow cytometry for various prognostic factors showed a high malignant potential of this tumor. Preoperative transurethral instrumentation for the treatment of urethral strictures may...

...Peter Henriksson; Birgitta Linde Patients with prostatic carcinoma were randomised to treatment with surgical castration (n = 47) or oral oestrogen therapy (n = 53). The oestrogen-treated patients received oral ethinyl oestradiol daily, 1 mg for the first 2 weeks followed by 150 µg. In addition...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic carcinoma Metastases Biopsy Urol Int 1990;45:370-371 ©1990 S. Karger AG. Basel 0042-1138/90/0456-037052.75/0 Perineal Seeding of Prostatic Carcinoma after...

...H. Al-Abadi; R. Nagel The ploidy, DNA heterogeneity and the phases of the cell cycle of the tumor were analyzed, by means of single-cell DNA cytophotometry, in 329 patients with locally advanced prostatic carcinoma to find out and establish prognostic factors apart from those already known (stage...

...P. Kristiansen; D. Bergqvist; L. Janzon; P. Pompeius Administration of estrogen as a treatment of patients with prostatic carcinoma has been correlated with an increase in the frequency of cardiovascular complications. The purpose of the present autopsy investigation was to study the incidence...

...Herbert Oelschläger; Dietrich Rothley; Udo Dunzendorfer For more than 30 years Fosfestrol (Honvan®) has been used as an estrogen for successful palliative therapy of prostatic carcinoma, but the pharmacokinetics of this compound were unknown due to the lack of analytical methods. Over the last few...

.... The benefits of DESDP have been ascribed to its specific cytotoxic activity towards prostatic carcinoma cells. To evaluate the tissue specificity of the cytotoxic effect, we exposed three prostatic carcinoma cell lines (LNCaP, DU 145, and PC-3), three non-prostatic neoplastic cell lines (KB: epidermoid...

...R. Tomić; J.-E. Damber Serum concentrations of testosterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were determined before and after orchidectomy performed at different intervals (2–29 months) after withdrawal of estrogen therapy in patients with prostatic carcinoma...

...Carlos D. Jurincic; Hans U. Pixberg; Alexander Gasser; Karl-Friedrich Klippel To evaluate the clinical and prognostic value of prostate-specific antigen (PSA) for the detection of tumor and tumor growth after therapy, 520 sera from 246 patients with prostatic carcinoma, 990 sera from patients...

... of the bladder Prostatic carcinoma Case Report Urol. int. 40:116-119 (1985) © 1985 S. Karger AG, Basel 0042-1138/85/0402-0116S2.75/0 Signet-Ring Cell Carcinoma of the Bladder and the Prostate Report of 4 Cases J.J.M. Kums, P.J.R.O. van Helsdingen Department of Urology (Head Felderhof.) Leyenburg Teaching...

...Tohru Shinkawa; Tetsuro Ohfuji; Yukio Osada; Nobuyuki Ishisawa A clinical study of the adverse effects induced by the endocrine therapy with a high dose of estrogen in 45 patients with stage C or D prostatic carcinoma is conducted. Transient decreases of hemoglobin and serum protein values were...

...B. Helpap The combined histologic and cytologic grading of carcinomas of the prostate is not only important in evaluation of prognosis but determines the choice of therapy with knowledge of staging. Tissue biopsies of 2,200 prostatic carcinomas were classified and graded histologically...

...J. Braun; R. Hofmann; H. Czempiel Transrectal ultrasound of the prostate is a cheap and well-reproducible examination for the prostate and seminal vesicles. The local tumor extension of a prostatic carcinoma can be visualized. By documentation of the ultrasound image on a polaroid paper picture...

... to in the content or advertisements. Prostatic carcinoma Non-Hodgkin lymphoma Concomitant malignancies Urol. int. 39: 121-122 (1984) ©1984 S. Karger AG, Basel 0042-1138/84/0392-0121 $2.75/0 Prostatic Carcinoma with Concomitant Non-Hodgkin Lymphoma Report of 2 Cases Reuven Gros, Santiago Richter, Leon...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Pelvic lymph nodes Computerized tomography Lymphangiography Prostatic carcinoma Case Reports Urol. int. 39: 178-183...

...B. Schwemmer; A. Lehmer; R. Hofmann; J. Braun In patients with prostatic carcinoma, natural killer (NK) cell activity was monitored in a chromium release assay. Cells from the human myeloid cell line K 562 and from a human prostatic cancer cell line (PC 3) were used as target cells. Additionally...